Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K2P18.1) Background Potassium Channel
Molecular Pharmacology - United States
doi 10.1124/mol.118.115626
Full Text
Open PDFAbstract
Available in full text
Date
April 12, 2019
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)